Inactive Instrument

Champions Oncology Inc Stock OTC Bulletin Board

Equities

US15870P1093

Biotechnology & Medical Research

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for Champions Oncology Inc
Sales 2024 * 48.84M Sales 2025 * 53.68M Capitalization 68.78M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 1.41 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 1.28 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 73.79%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 58 10-10-25
President - 23-10-16
Chairman 59 10-10-25
Members of the board TitleAgeSince
Founder 64 07-12-31
Director/Board Member 53 11-06-26
Chairman 59 10-10-25
More insiders
Champions Oncology, Inc. is a technology-enabled research organization engaged in creating transformative technology solutions to be utilized in drug discovery and development. The Company's research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The Company’s TumorGraft Technology Platform (The Platform) provides select services to pharmaceutical and biotechnology companies. Its software as-a-service business is centered around its software platform and data tool, Lumin Bioinformatics (Lumin), which contains comprehensive information derived from its research services and clinical studies. Its drug discovery and development business leverage the computational and experimental capabilities within its platforms. Its discovery strategy utilizes its datacenter, coupled with artificial intelligence and other advanced computational analytics, to identify therapeutic targets.
More about the company